Henn Matthew R bought MCRB
September 26, 2025 · Form 4 insider transaction
Henn Matthew R bought 3,998 shares of Seres Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,998
Price
$0.00
Total value
N/A
InsiderHenn Matthew R
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateSeptember 26, 2025
Filing dateSeptember 30, 2025
Shares owned after3,998
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.; The RSUs will vest in a single installment on November 15, 2025, subject to the Reporting Person's satisfaction of the terms contemplated in the award agreement.The RSUs have no expiration date.